Innovative Biosensing Sava specializes in advanced biosensing technology that enables painless, real-time, and affordable health data access, positioning it as a leader in wearable health monitoring solutions ideal for healthcare providers and wellness product markets seeking to enhance patient engagement.

Growing Market Focus With a focus on central nervous system disorders and innovative investigational treatments, Sava presents opportunities for sales of biotech tools, clinical trial support services, and partnerships with pharmaceutical and research organizations focused on CNS therapies.

Financial Position With current annual revenues between 1 million and 10 million dollars and funding of 19 million dollars, Sava has the financial flexibility to invest in expanding its biosensing capabilities and develop new clinical applications, opening avenues for sales of advanced sensing hardware and related technologies.

Regulatory & Legal Engagements Recent legal investigations and FDA interactions highlight the importance of compliance and regulatory support, creating potential sales opportunities for legal, regulatory consulting, and compliance solutions tailored for biotech companies navigating complex approval processes.

Market Visibility & Collaboration Recent appointments to the board and active investor engagement indicate Sava's focus on strategic growth and partnerships, providing opportunities for business development in joint ventures, co-development projects, and strategic alliances within the biotech and healthcare sectors.